Why is Senores Pharma. falling/rising?

As of 29-Aug, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 689.45, reflecting a decrease of Rs 6.3 or 0.91%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total return of -4.73% over the past week. Today's trading saw the stock reach a high of Rs 712 and a low of Rs 675.35, with more volume traded closer to the low price. Despite a healthy long-term growth trajectory indicated by significant increases in net sales and operating profit, the stock's valuation appears expensive, with a high price-to-book ratio and a relatively low return on equity of 7.4. Additionally, there has been a decrease in institutional investor participation, which may contribute to the stock's downward pressure. In the broader market context, Senores Pharmaceuticals has underperformed compared to the Sensex, which has declined by 1.84% over the past week, while the stock itself has dropped by 4.73%. This indicates that the stock's short-term performance is significantly worse than the benchmark. The overall market sentiment may be affecting investor confidence, particularly given the falling participation from institutional investors who typically have more resources to analyze company fundamentals. The combination of these factors suggests that while the company has strong growth metrics, the current market dynamics and valuation concerns are leading to a decline in its stock price.